Cystic fibrosis year in review 2018, part 2.

Adrienne P Savant, Susanna A McColley

Journal: Pediatric pulmonology 2020;54(8):1129-1140

PMID: 31125191

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Cystic fibrosis (CF) research and case reports were robust in the year 2018. This report summarizes publications related the multisystem effects of CF, pulmonary exacerbations, new and expanded therapies other than cystic fibrosis transmembrane conductance regulator modulator studies, and patient-reported priorities and outcomes.

Address: Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois.; Clinical and Translational Research, Stanley Manne Children's Research Institute, Chicago, Illinois.; Division of Pulmonary and Sleep Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.

DOI: 10.1002/ppul.24365

Link outs

Free resources

Medical:

Subscription / membership required

Full Text Sources:

MeSH Terms: Cystic Fibrosis, Humans, Lung, Patient Reported Outcome Measures